Transitional cell carcinoma medical therapy

Jump to navigation Jump to search

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma medical therapy

CDC on Transitional cell carcinoma medical therapy

Transitional cell carcinoma medical therapy in the news

Blogs on Transitional cell carcinoma medical therapy

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatment options

Treatment depends on the stage of the cancer, the severity of your symptoms, and your overall health.

  • Stage 0 and I treatments:
    • Surgery to remove the tumor without removing the rest of the bladder

Chemotherapy or immunotherapy directly into the bladder

  • Stage II and III treatments:
    • Surgery to remove the entire bladder (radical cystectomy)
    • Surgery to remove only part of the bladder, followed by radiation and chemotherapy
    • Chemotherapy to shrink the tumor before surgery
    • A combination of chemotherapy and radiation (in patients who choose not to have surgery or who cannot have surgery)

Most patients with stage IV tumors cannot be cured and surgery is not appropriate. In these patients, chemotherapy is often considered.

CHEMOTHERAPY

  • Chemotherapy may be given to patients with stage II and III disease either before or after surgery to help prevent the tumor from returning.
  • For early disease (stages 0 and I), chemotherapy is usually given directly into the bladder.
  • A Foley catheter can be used to deliver the medication into the bladder.
  • For more advanced stages (II-IV), chemotherapy is usually given by vein (intravenously).

IMMUNOTHERAPY

Bladder cancers are often treated with immunotherapy. In this treatment, a medication triggers your immune system to attack and kill the cancer cells. Immunotherapy for bladder cancer is usually performed using the Bacille Calmette-Guerin vaccine (commonly known as BCG). It is given through a Foley catheter directly into the bladder. If BCG does not work, patients may receive interferon.

As with all treatments, side effects are possible. Ask your doctor what side effects you might expect, and what to do if they occur.

References

Template:WH Template:WS